Associate Director, Translational Science Employer Legend Biotech Location Somerset, New Jersey Salary $168372

• $220988 Start date Sep 10, 2026 View more categories View less categories Discipline Information Technology , Bioinformatics , Science/R D , Computational Science , Immunology Required Education Doctorate/PHD/MD Position Type Full time Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job.

Send job Job Details Company Job Details Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide. Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize

CARVYKTI

® (ciltacabtagene autoleucel; cilta-cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma. Legend Biotech is seeking an Associate Director, Translational Science as part of the Early Drug Development team based in Somerset, NJ . Role Overview The Associate Director of Translational Science will bridge the gap between early-stage discovery research and clinical development. This role requires a unique blend of deep immunological expertise and advanced computational proficiency. You will be responsible for designing and executing translational strategies, identifying biomarkers, and leveraging large-scale multi-omic datasets to provide actionable insights into mechanism of action (MoA), patient stratification, and drug resistance in both autoimmune and oncology disease area.

Key Responsibilities Translational Strategy:

Lead the development and execution of program-specific translational plans from lead optimization through Phase II clinical trials.

Data Integration & Analysis:

Oversee the analysis of high-dimensional datasets (e.g., scRNA-seq, CITE-seq, flow cytometry, and spatial transcriptomics) to identify pharmacodynamic markers and predictive signatures, to interpret and provide insight into the biological mechanisms.

Clinical Collaboration:

Partner with Clinical Development and Clinical Operations to implement biomarker assays in clinical protocols and ensure high-quality data collection.

External Partnerships:

Manage relationships with Contract Research Organizations (CROs) and academic collaborators for specialized assay development and advanced data processing.

Cross-Functional Leadership:

Represent Translational Science on program teams, providing expert input on disease biology, target engagement, and competitive landscape.

Scientific Communication:

Author high-quality technical reports, regulatory documents (IND/IB/NDA), and contribute to peer-reviewed publications and conference presentations. Requirements PhD or MD/PhD in Immunology, Bioinformatics, Computational Biology, or a related field. 5+ years of experience in the biopharmaceutical industry or an equivalent academic leadership role within translational research. Extensive knowledge of human auto-immune disease and oncology diseases, specifically in areas such as immuno-oncology, autoimmune diseases, or cell therapy (CAR-T/TCR-T). Demonstrated experience with genomic data analysis. Practical and hand on experience data analysis pipeline, ability to guide data integration, knowledge integration from multiple datasets is essential. Proven track record in the development, validation, and clinical implementation of complex biomarkers. Experience working with relevant disease areas, deep understanding of the biological mechanisms related to diseases(auto-immune, oncology, or/both). Strong understanding of regulatory requirements for biomarker-driven clinical trials. Excellent project management skills with the ability to lead multiple programs in a fast-paced environment. High scientific curiosity, driven, motivated in deep understanding of the biology behind both disease and therapies. #Li-AS1 #Li-Hybrid The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.

Other Types of Pay:

Performance-based bonus and/or equity is available to employees in eligible roles.

Benefits and Paid Time Off:

Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short

• and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance.

We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work. Pay Range (Base Pay): $168,372

• $220,988 USD Please note: These benefits are offered exclusively to permanent full-time employees.

Contractors are not eligible for benefits through Legend Biotech. Work Authorization & Employment Eligibility Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates. EEO Statement It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances. Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company. For information related to our privacy notice, please review: Legend Biotech Privacy Notice . Company Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap. For two years, Legend Biotech, then known as the "Legend Project," operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies. In 2015, Legend's scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China. In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world.

CARVYKTI

™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022. Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies. Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies. Company info Location Somerset New Jersey United States Share this job Facebook Twitter LinkedIn Apply now Send job Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Get job alerts Create a job alert and receive personalized job recommendations straight to your inbox. Create alert Similar jobs Director, Immunology

• San Diego, CA San Diego, CA Medical Science Liaison
• Obesity
• Western FL Tampa, Florida Medical Science Liaison, IgG4
• Rare Disease
• UT, AZ Phoenix, Arizona